Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.61 USD | +2.94% | +10.87% | -27.98% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.98% | 150M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.28% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals : Wedbush Adjusts Syros Pharmaceuticals' Price Target to $8 From $10, Maintains Neutral Rating